despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6..

..

.

maslow's ideas deserve to be better understood so they can be developed and built upon. by alex fradera..

"we were quite surprised to find there were no significant differences," says study author